Search

Search Constraints

You searched for: Author/Creator Nikolinakos, Petros G.

Search Results

1. A phase 1/2 trial of ublituximab, a novel anti‐CD20 monoclonal antibody, in patients with B‐cell non‐Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab. (21st February 2017)

2. Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI. Issue 3 (September 2015)

3. Fundamentals of integrated ferrohydrodynamic cell separation in circulating tumor cell isolation. Issue 9 (15th March 2021)

5. PRONOUNCE. Issue 1 (January 2015)

6. PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer. Issue 1 (January 2015)

7. Simultaneous biochemical and functional phenotyping of single circulating tumor cells using ultrahigh throughput and recovery microfluidic devices. Issue 18 (4th August 2021)

8. Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells. Issue 10 (1st May 2019)

9. Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells. Issue 10 (1st May 2019)